CoChat

Shortening the duration of treatment for cervical tuberculous lymphadenitis

Open access
van Loenhout-Rooyackers, JH, Laheij, RJ, Richter, C, Verbeek, AL · 2000 · European Respiratory Journal

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The aim of the study was to determine the optimal duration of treatment for patients with tuberculous lymphadenitis. The Medline database was searched for relevant articles published between 1978-1997. Inclusion criteria were study populations of patients with predominantly cervical tuberculous lymphadenitis in whom the diagnosis had been confirmed bacteriologically and/or histologically, or was made probable by using clinical and laboratory markers. Treatment management had to include at least isoniazid, rifampicin and pyrazinamide and a follow-up of at least 12 months after the end of treatment. Patients with resistance to rifampicin and pyrazinamide and previous treatment for tuberculosis were excluded. The number of patients who relapsed after treatment was calculated. The study population in eight out of the 35 articles retrieved were suitable for analysis. Some concerned comparative studies. There were eight treatment schedules of 6 months' duration and three schedules of 9 months' duration. Treatment for 6 months resulted in a tuberculous lymphadenitis relapse rate of 13/422=3.3% (95% confidence interval: 1.7-5.5), with a mean follow-up of 31 months after completion of treatment. Treatment for 9 months resulted in a relapse rate of 3/112=2.7% (95% confidence interval: 0.6-7.8), with a mean follow-up of 20 months. Despite the limitations of the literature available, 6 months of therapy is probably sufficient for patients with tuberculous lymphadenitis.

Overview

Integrity signals

Registry

Crossref · 10.1183/09031936.00.15119200

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Cited by

See all 65

Metadata

Authors
van Loenhout-Rooyackers, J., Laheij, R., Richter, C., & Verbeek, A.
Affiliations
  • Radboud University Nijmegen (NL)
  • Rijnstate Hospital (NL)
Venue
European Respiratory Journal
Published
2000-01-01
Volume
15
Issue
1
Pages
192-195
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2145192125
Cited by
62
References
17
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculous lymphadenitis, cervical lymphadenitis, treatment duration, isoniazid, rifampicin, pyrazinamide, relapse rate, tuberculosis treatment
MeSH terms
Antitubercular Agents, Drug Administration Schedule, Drug Therapy, Combination, Follow-Up Studies, Humans, Isoniazid, Neck, Pyrazinamide, Rifampin, Tuberculosis, Lymph Node, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shortening the duration of treatment for cervical tuberculous lymphadenitis. https://app.cochat.ai/papers/10.1183/09031936.00.15119200
The paper
van Loenhout-Rooyackers, J., Laheij, R., Richter, C., & Verbeek, A. (2000). Shortening the duration of treatment for cervical tuberculous lymphadenitis. European Respiratory Journal. https://doi.org/10.1183/09031936.00.15119200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.